ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ABEBF Abera Bioscience AB (GM)

0.00
0.00 (0.00%)

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 201820192020202120222023
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Total Assets 2.42M4.89M2.97M31.37M19.57M9.35M
Total Current Assets 534k3M1.08M12.44M17.69M7.46M
Cash and Equivalents 497k2.65M902k11.95M15.43M3.32M
Total Non-Current Assets 757k3.95M428k29.15M16.78M5.66M
Total Liabilities 1.66M937k2.54M2.22M2.8M3.69M
Total Current Liabilities 1.66M937k2.54M2.22M2.8M3.69M
Total Non-Current Liabilities 000000
Total Equity 757k3.95M428k29.15M16.78M5.66M
Common Equity 72k95k558k837k1.03M1.16M
Retained Earnings -9.09M-11.92M-15.56M-24.73M-44.11M-60.36M

Your Recent History

Delayed Upgrade Clock